ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Satisfying unmet medical needs Information due to Covid-19 Immedica has been following closely all developments relating to COVID-19 with a heightened sense of responsibility towards our employees, the medical community, the patients addressed by our products and the broader society. As such we adjust day by day our working practices and activities to be compliant with the recommendations from relevant authorities, mitigating the spread of COVID-19 and ensure the delivery of the products to our patients and partners. All functions are staffed and we work primarily through our digital channels both internally and externally. CONTACT Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Oncology / Haematology Ovarian Cancer Ovarian Cancer Ovarian Cancer is a disease in which cancer cells are found in the ovaries. In addition to forming in the ovary, cancers that form in the nearby fallopian tube or in the peritoneum (the membrane that lines the abdominal cavity) and spread to the ovary are often considered ovarian cancer, therefore following the same course of treatment. Most ovarian cancers form after menopause, with over half being found in women of 63 years of age or older.1 Two or more different types of treatment are most commonly used to treat ovarian cancer. Surgery is the primary treatment for ovarian cancer and is used to both correctly evaluate the cancer and to remove as much of the cancerous material as possible. Other treatments include the use of one or more chemotherapeutic agents, targeted therapy, which unlike traditional chemotherapy, specifically targets cancer cells, and radiation therapy. Additionally, for ovarian stromal tumours, hormone therapy may be used.1 Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica

ABOUT US PARTNER WITH US THERAPEUTIC AREAS PRODUCTS NEWS/PRESS SHARING CONTACT Thomas Eklund Chairman of the board Read more Lisa Bright Board member Read more Magnus Edlund Board member Read more Fredrik Holmström Board observer Read more Stefan Larsson Board member Read more Kerstin Valinder Board member Read more Peder Walberg Board member Read more Privacy policy | Term of Use | Code of Conduct Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm Sweden E-mail: info@immedica.com Phone: +46(0)8 533 39 500 © 2021 All rights Reserved. Design by Immedica